Contents

Current Cancer Drug Targets, Volume 3 - Number 6

Hypoxia Inducible Factor as a Cancer Drug Target

, 3(6): 391 - 405

Sarah J. Welsh and Garth Powis


DOI: 10.2174/1568009033481732




Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules

, 3(6): 407 - 426

Christian Lavagna, Piero Del Soldato, Jean-Luc Burgaud and Patrick Rampal


DOI: 10.2174/1568009033481750




Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies

, 3(6): 427 - 432

E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte and M. Maio


DOI: 10.2174/1568009033481741




Thomsen-Friedenreich Disaccharide Immunogenicity

, 3(6): 433 - 443

Fernando J. Irazoqui and Gustavo A. Nores


DOI: 10.2174/1568009033481714




Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)

, 3(6): 445 - 453

Laszlo G. Boros, Daniel J. Brackett and George G. Harrigan


DOI: 10.2174/1568009033481769




Cyclooxygenase Inhibition and Mechanisms of Colorectal Cancer Prevention

, 3(6): 455 - 463

Timothy A. Chan


DOI: 10.2174/1568009033481723




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science